Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Holt

Showing results (21-30 of 219) with videos related to

Pageof 22
Sort By:
Clinical Chemistry|December 1, 1993
Calibration of the CYCLO-Trac SP cyclosporine radioimmunoassayA Johnston, D W Holt
British Journal of Clinical Pharmacology|May 8, 1999
Therapeutic drug monitoring of immunosuppressant drugsA Johnston, D W Holt
Transplantation Proceedings|May 20, 1999
Bioequivalence criteria for cyclosporineA Johnston, D W Holt
Transplantation Proceedings|December 20, 2000
The impact of cyclosporin formulation on clinical outcomesD W Holt, A Johnston
Therapeutic Drug Monitoring|December 1, 1995
Cyclosporin A: analytical methodology and factors affecting therapeutic drug monitoringD W Holt, A Johnston
British Journal of Hospital Medicine|April 3, 1996
Immunotherapy in organ transplantationD W Holt, A Johnston
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1993
External quality assessment scheme for cyclosporin in body fluidsA Johnston, D W Holt
Transplantation|December 15, 1995
Cyclosporine dosingA Johnston, D W Holt
Clinical Chemistry|July 1, 1989
The relevance of pharmacokinetics to monitoring new antiarrhythmicsD W Holt, A Johnston
Lancet (London, England)|March 3, 1979
Complications of disopyramideD W Holt, A M Hayler
Pageof 22

Showing results (21-30 of 219) with videos related to

Sort By:
Pageof 22
Clinical Chemistry|December 1, 1993
Calibration of the CYCLO-Trac SP cyclosporine radioimmunoassayA Johnston, D W Holt
British Journal of Clinical Pharmacology|May 8, 1999
Therapeutic drug monitoring of immunosuppressant drugsA Johnston, D W Holt
Transplantation Proceedings|May 20, 1999
Bioequivalence criteria for cyclosporineA Johnston, D W Holt
Transplantation Proceedings|December 20, 2000
The impact of cyclosporin formulation on clinical outcomesD W Holt, A Johnston
Therapeutic Drug Monitoring|December 1, 1995
Cyclosporin A: analytical methodology and factors affecting therapeutic drug monitoringD W Holt, A Johnston
British Journal of Hospital Medicine|April 3, 1996
Immunotherapy in organ transplantationD W Holt, A Johnston
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1993
External quality assessment scheme for cyclosporin in body fluidsA Johnston, D W Holt
Transplantation|December 15, 1995
Cyclosporine dosingA Johnston, D W Holt
Clinical Chemistry|July 1, 1989
The relevance of pharmacokinetics to monitoring new antiarrhythmicsD W Holt, A Johnston
Lancet (London, England)|March 3, 1979
Complications of disopyramideD W Holt, A M Hayler
Pageof 22